G Airagnes
Overview
Explore the profile of G Airagnes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valter R, Nezet O, Obradovic I, Spilka S, Falissard B, Josseran L, et al.
Soc Psychiatry Psychiatr Epidemiol
. 2025 Feb;
PMID: 39966163
Purpose: Recent changes in the cannabis market, including decreased adolescence usage, increased Δ9-tetrahydrocannabinol levels and rising mental disorders over the last decade raises questions about the changing profile of cannabis...
2.
Hoertel N, Sanchez-Rico M, Gulbins E, Kornhuber J, Vernet R, Beeker N, et al.
Epidemiol Psychiatr Sci
. 2022 Mar;
31:e18.
PMID: 35352674
Aims: To examine the association between benzodiazepine receptor agonist (BZRA) use and mortality in patients hospitalised for coronavirus disease 2019 (COVID-19). Methods: A multicentre observational study was performed at Greater...
3.
Oliveira Bekkers E, Ducoutumany G, Tran Luy M, Airagnes G, Limosin F, Le Faou A
Rev Mal Respir
. 2022 Feb;
39(3):212-220.
PMID: 35210125
Introduction: A survey on smoking prevalence was conducted among staff at the Georges Pompidou and Corentin Celton hospitals in the framework of the "smoke-free hospital" project. It aimed to determine...
4.
Rakover A, Allagbe I, Airagnes G, Limosin F, Le Faou A
Rev Mal Respir
. 2021 May;
38(5):443-454.
PMID: 33994042
Introduction: In November 2016, France implemented "Mois sans tabac", with the objective of promoting smoking cessation in November for at least one month. This study consisted of: (1) the description...
5.
Matta J, Hoertel N, Airagnes G, Wiernik E, Limosin F, Goldberg M, et al.
Compr Psychiatry
. 2020 Sep;
102:152203.
PMID: 32927368
Background: The role of alcohol, tobacco and cannabis use in social differences in terms of depression is poorly understood. Method: We have applied mediation and moderated-mediation models stratified by gender...
6.
Tran Luy M, Le Faou A, Airagnes G, Limosin F
Rev Mal Respir
. 2020 Sep;
37(8):644-651.
PMID: 32883549
Introduction: The prevalence of daily smoking in France was 24 % in 2019 and tobacco control remains a major public health issue. A hospital stay provides an opportunity for smoking...
7.
Touchard J, Sabatier P, Airagnes G, Berdot S, Sabatier B
Eur J Clin Pharmacol
. 2019 Oct;
76(1):89-95.
PMID: 31608425
Purpose: To determine changes in the prevalence of zolpidem consumption since the change in the regulations of prescription. Formulations containing zolpidem were subject to the regulations of narcotics by the...
8.
Airagnes G, Ducoutumany G, Laffy-Beaufils B, Le Faou A, Limosin F
Rev Med Interne
. 2019 Mar;
40(6):373-379.
PMID: 30853380
Patients with alcohol use disorder experience frequently alcohol withdrawal syndrome (AWS), which is a potentially life-threatening condition mainly caused by glutamate overactivity. The aim of therapeutic alcohol withdrawal is the...
9.
Hinfray S, Airagnes G, Le Faou A, Ducoutumany G, Louville P, Lemogne C, et al.
Rev Med Interne
. 2018 Dec;
40(6):355-360.
PMID: 30545574
Introduction: By using a standardized and systematic screening with the FACE questionnaire, our aims were : - to determine the prevalence of alcohol misuse (AM) among patients admitted in the...
10.
Abdul-Kader J, Airagnes G, dAlmeida S, Limosin F, Le Faou A
Rev Pneumol Clin
. 2018 Apr;
74(3):160-169.
PMID: 29650283
Smoking cessation treatments have been proved effective to stop smoking. For pharmacological treatments, nicotine replacement therapies (NRT) as well as bupropion allow to increase 6 month-abstinence rates by more than...